Search Orphan Drug Designations and Approvals
-
Generic Name: | (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide hydrate |
---|---|
Date Designated: | 06/15/2017 |
Orphan Designation: | Treatment of Pediatric Crohn's disease |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
AbbVie 1 North Waukegan Road North Chicago, Illinois 60044 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
-